Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newton, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Acumen Pharmaceuticals, Inc. has filed 354 SEC EDGAR filings since 15 May 2013

SEC filing history

Showing 201-225 of 354 matching filings.

Per page
25
Current page
9
4

FORM 4

Filing date
04 Jan 2024
Reporting date
02 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40551

144 filing

Filing date
17 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92677

SC 13D/A

Filing date
25 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
25 Jul 2023
Reporting date
21 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-266004

424B5

Filing date
20 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-266004

424B5

Filing date
17 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2023
Reporting date
06 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .